The world's first targeted human interleukin-5 antibody biologics approved for marketing, Xin Kelai debuts at the 4th CIIE
Contact Us
Trade Alert - Delivering the latest product trends and industry news straight to your inbox.
(We`ll never share your email address with a third-party.)
鲁ICP备16009155号-1 | Copyright@Qingdao ECHEMI Technology Co., Ltd.
Welcome to ECHEMI